About the Prolaris RP Test

The Prolaris® Radical Prostatectomy (RP) test provides an analysis of your individual tumor aggressiveness as well as a clinically validated prostate cancer-specific mortality risk. This test, designed to be used in patients who present with high-risk pathology after prostate removal surgery,  utilizes a patient's final pathology tissue to calculate a Prolaris Score.  

 

This score, combined with the genomic profile of your tumor, helps to determine the aggressiveness of your cancer compared to individuals with similar disease characteristics, and computes your relative 10-year risk of biochemical recurrence. With this information, you and your healthcare provider can develop a treatment or monitoring plan that best suits your individual needs.  

Patient Resources:

Below are several resources designed to help patients and their family better understand how the Prolaris RP test is used in a clinical setting, including a video as well as downloadable brochures. 

PCMs Brochure

This brochure, designed by pcmarkers.com, will help patients and their family further understand the test. 

Prolaris RP Brochure

This brochure, designed by Myraid, will help patients and their family further understand the test. 

Prolaris RP Sample Report

This sample report will help patients and their families understand how the results for this test are presented. 

Aurora, Colorado | Info@pcmarkers.com